Skip to main content
PVLA logo
PVLA
(NASDAQ)
Palvella Therapeutics, Inc.
$142.18-- (--)
Loading... - Market loading

Palvella Therapeutics (PVLA) Stock Price & Financial Analysis

Palvella Therapeutics Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$138.12 - $144.10
52-Week High$161.38
52-Week Low$29.38
Open$140.65
Volume134.60K
Average Volume (3M)302.88K
Market Cap1.61B
Shares Outstanding11.25M
Price to Book (P/B)59.41
EV/EBITDA-32.37
50-Day MA$125.08
200-Day MA$105.88
52-Week Change373.17%
Annual Dividend$0.00
Dividend Yield0.00%

Frequently Asked Questions About Palvella Therapeutics

What is the current stock price for PVLA?

As of the latest trading session, PVLA stock trades at $143.21. The 52-week range is $29.38–$161.38, with a day range of $138.12–$144.09.

What is the P/E ratio for PVLA?

The P/E ratio (Price-to-Earnings) for PVLA is shown in the Key Statistics section. This valuation metric helps compare Palvella Therapeutics, Inc. to industry peers.

Does PVLA pay dividends?

Palvella Therapeutics does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.

What do analysts recommend for PVLA?

Based on 10 analysts, the consensus for PVLA is Buy.

What is the market cap of PVLA?

Palvella Therapeutics's market capitalization is $1.61B, classifying it as a small-cap company. Palvella Therapeutics operates in the Healthcare sector within the Biotechnology industry.